O
Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
401
Larimar Therapeutics
LRMR
$331M
|
AA
Andreas Argyrides
| $3.87 | $26 |
572%
upside
| Outperform |
16 Oct ‘24
10 months ago |
|
402
Zimmer Biomet
ZBH
$20.7B
|
SL
Steven Lichtman
| $103.85 | $135 |
30%
upside
| Outperform |
15 Oct ‘24
11 months ago |
|
403
Avient
AVNT
$3.47B
|
KO
Kristen Owen
| $36.98 | $58 |
57%
upside
| Outperform |
14 Oct ‘24
11 months ago |
|
404
Saratoga Investment
SAR
$395M
|
MP
Mitchel Penn
| $24.54 | $25 |
2%
upside
| Perform |
10 Oct ‘24
11 months ago |
|
405
Immunovant
IMVT
$2.86B
|
LG
Leland Gershell
| $16.40 | $53 |
223%
upside
| Outperform |
9 Oct ‘24
11 months ago |
|
406
Abbott
ABT
$230B
|
SK
Suraj Kalia
| $131.95 | $130 |
1%
downside
| Outperform |
8 Oct ‘24
11 months ago |
|
407
CION Investment
CION
$525M
|
MP
Mitchel Penn
| $10.01 | $13 |
30%
upside
| Perform |
8 Oct ‘24
11 months ago |
|
408
CarMax
KMX
$9.21B
|
BN
Brian Nagel
| $61.38 | $105 |
71%
upside
| Outperform |
4 Oct ‘24
11 months ago |
|
409
Carrier Global
CARR
$54B
|
NK
Noah Kaye
| $63.47 | $88 |
39%
upside
| Outperform |
2 Oct ‘24
11 months ago |
|
410
Jack Henry & Associates
JKHY
$11.9B
|
RK
Rayna Kumar
| $162.75 | $206 |
27%
upside
| Outperform |
1 Oct ‘24
11 months ago |
|
411
Uber
UBER
$199B
|
JH
Jason Helfstein
| $95.45 | $95 |
0%
downside
| Outperform |
27 Sep ‘24
11 months ago |
|
412
Emerson Electric
EMR
$74.7B
|
CG
Christopher Glynn
| $132.05 | $125 |
5%
downside
| Outperform |
26 Sep ‘24
11 months ago |
|
413
Viking Therapeutics
VKTX
$2.84B
|
JO
Jay Olson
| $25.27 | $138 |
446%
upside
| Outperform |
25 Sep ‘24
11 months ago |
|
414
enGene Holdings
ENGN
$278M
|
LG
Leland Gershell
| $5.55 | $30 |
441%
upside
| Outperform |
24 Sep ‘24
11 months ago |
|
415
Lowe's Companies
LOW
$153B
|
BN
Brian Nagel
| $269.03 | $305 |
13%
upside
| Outperform |
24 Sep ‘24
11 months ago |
|
416
Home Depot
HD
$418B
|
TH
Timothy Horan
| $415.34 | $400 |
4%
downside
| Perform |
24 Sep ‘24
11 months ago |
|
417
Addus HomeCare
ADUS
$2.11B
|
MW
Michael Wiederhorn
| $113.05 | $145 |
28%
upside
| Outperform |
23 Sep ‘24
11 months ago |
|
418
Tyra Biosciences
TYRA
$646M
|
MB
Matthew Biegler
| $11.82 | $33 |
179%
upside
| Outperform |
19 Sep ‘24
11 months ago |
|
419
Zentalis Pharmaceuticals
ZNTL
$118M
|
MB
Matthew Biegler
| $1.60 | $20 |
1,150%
upside
| Outperform |
16 Sep ‘24
11 months ago |
|
420
TriSalus Life Sciences
TLSI
$250M
|
SK
Suraj Kalia
| $4.90 | $10 |
104%
upside
| Outperform |
16 Sep ‘24
11 months ago |
|
421
SAB Biotherapeutics
SABS
$21.9M
|
LG
Leland Gershell
| $2.13 | $12 |
463%
upside
| Outperform |
12 Sep ‘24
1 year ago |
|
422
Edwards Lifesciences
EW
$46.9B
|
SK
Suraj Kalia
| $79.80 | $90 |
13%
upside
| Outperform |
12 Sep ‘24
1 year ago |
|
423
Pharvaris
PHVS
$1.4B
|
JK
Justin Kim
| $23.94 | $42 |
75%
upside
| Outperform |
6 Sep ‘24
1 year ago |
|
424
Couchbase
BASE
$1.35B
|
IK
Ittai Kidron
| $24.43 | $23 |
6%
downside
| Outperform |
5 Sep ‘24
1 year ago |
|
425
Nurix Therapeutics
NRIX
$742M
|
MB
Mark Breidenbach
| $9.20 | $30 |
226%
upside
| Outperform |
4 Sep ‘24
1 year ago |
|